HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endothelin-A receptor antagonist BQ123 potentiates acetaminophen induced hypothermia and reduces infarction following focal cerebral ischemia in rats.

Abstract
Endothelin antagonists are being investigated to prevent neuronal loss after cerebral ischemia. Acetaminophen has been tried in stroke patients to produce hypothermia so that injury following cerebral ischemia can be reduced. The aim of this study was to assess the effect of BQ123, an endothelin-A receptor antagonist, alone and in combination with acetaminophen on neurological outcome, oxidative stress and infarct volume in rats subjected to focal ischemia by occlusion of the middle cerebral artery. In normal rats, acetaminophen decreased, while BQ123 did not produce any change in body temperature, but rats treated with BQ123 and acetaminophen produced a significantly greater (41%) hypothermic response compared to acetaminophen group. In rats subjected to middle cerebral artery occlusion, neurologic deficit was observed; acetaminophen alone did not improve, but BQ123 alone and in combination with acetaminophen produced a significant improvement in neurological deficit. The level of malondialdehyde (MDA) increased and reduced glutathione (GSH) decreased in the brain following ischemia; acetaminophen did not but BQ123 alone and in combination with acetaminophen decreased MDA and increased GSH levels in ischemic rats. Cerebral ischemia produced significant infarction, the infarct volume decreased in response to BQ123 and its combination with acetaminophen. The infarct volume, MDA level and neurological deficit in ischemic rats significantly improved in rats treated with both BQ123 and acetaminophen compared to BQ123 alone. The results demonstrate that a combination of acetaminophen and BQ123 is more effective in reducing the neuronal damage following cerebral ischemia, and this combination may be worth investigating in stroke patients.
AuthorsSeema Briyal, Anil Gulati
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 644 Issue 1-3 Pg. 73-9 (Oct 10 2010) ISSN: 1879-0712 [Electronic] Netherlands
PMID20638381 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 Elsevier B.V. All rights reserved.
Chemical References
  • Antipyretics
  • Endothelin A Receptor Antagonists
  • Peptides, Cyclic
  • Acetaminophen
  • Malondialdehyde
  • Glutathione
  • cyclo(Trp-Asp-Pro-Val-Leu)
Topics
  • Acetaminophen (pharmacology)
  • Animals
  • Antipyretics (pharmacology)
  • Brain Ischemia (complications, drug therapy, physiopathology)
  • Disease Models, Animal
  • Drug Synergism
  • Endothelin A Receptor Antagonists
  • Glutathione (metabolism)
  • Hypothermia, Induced (methods)
  • Infarction, Middle Cerebral Artery (complications, drug therapy, physiopathology)
  • Male
  • Malondialdehyde (metabolism)
  • Oxidative Stress (drug effects)
  • Peptides, Cyclic (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Stroke (etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: